GAG-hed Inhibits HPV18 Activity
Author Information
Author(s): Villanueva Rita, Morales-Peza Néstor, Castelán-Sánchez Irma, García-Villa Enrique, Tapia Rocio, Cid-Arregui Ángel, García-Carrancá Alejandro, López-Bayghen Esther, Gariglio Patricio
Primary Institution: Centro de Investigación y de Estudios Avanzados, UNAM- Instituto Nacional de Cancerología
Hypothesis
Can GAG-hed serve as an antiviral and antitumoral agent against HPV18?
Conclusion
GAG-hed inhibits HPV18 transcription and cell proliferation by blocking AP1 binding.
Supporting Evidence
- GAG-hed treatment resulted in a significant decrease in E6/E7 mRNA expression in HeLa cells.
- Tumor growth was significantly inhibited in athymic mice treated with GAG-hed.
- GAG-hed blocked the binding of the transcription factor AP1 to HPV18-LCR.
- Cell proliferation rates decreased in HeLa cells treated with GAG-hed.
Takeaway
GAG-hed is a substance that can help stop the growth of cancer cells caused by a virus called HPV by preventing a specific protein from working.
Methodology
The study used in vivo and in vitro methods to assess the effects of GAG-hed on HeLa cells and tumor growth in mice.
Potential Biases
Potential bias in the selection of treatment doses and the specific cell lines used.
Limitations
The study primarily focused on a single cell line and animal model, which may limit the generalizability of the findings.
Participant Demographics
Athymic female mice were used for in vivo experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website